81.6  0.11 (0.13%)		01-30 15:47
Open: 81.6 High: 82.6 Volume: 1,684,153		Pre. Close: 81.49 Low: 80.75 Market Cap: 47,907(M)

Short term
Mid term
Targets	6-month :	99.01	1-year :	102.12
Resists	First :	84.77	Second :	87.44
Pivot price	83.57
Supports	First :	80.45	Second :	66.94
MAs	MA(5) :	82.59	MA(20) :	83.91
	MA(100) :	81.49	MA(250) :	77.68
MACD	MACD :	-0.7	Signal :	-0.4
%K %D	K(14,3) :	17.1	D(3) :	26.2
RSI	RSI(14): 39.9
52-week	High :	87.88	Low :	65.94

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ EW ] has closed above bottom band by 9.1%. Bollinger Bands are 28.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	82.62 - 83.29	83.29 - 83.75
Low:	79.07 - 79.81	79.81 - 80.3
Close:	80.51 - 81.67	81.67 - 82.44

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fri, 30 Jan 2026
Renewed Growth Cycle Drives a Favorable Sentiment Towards Edwards Lifesciences (EW) - Insider Monkey

Fri, 30 Jan 2026
Edwards Lifesciences Stock: What the Numbers Say After a 15% Gain Last Year - TIKR.com

Thu, 29 Jan 2026
Edwards Lifesciences launches $500M accelerated share buyback - MSN

Thu, 29 Jan 2026
J. Safra Sarasin Holding AG Buys New Shares in Edwards Lifesciences Corporation $EW - MarketBeat

Thu, 29 Jan 2026
Retirement Systems of Alabama Acquires Shares of 125,240 Edwards Lifesciences Corporation $EW - MarketBeat

Wed, 28 Jan 2026
Bank of New York Mellon Corp Increases Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	580 (M)
Shares Float	574 (M)
Held by Insiders	0.9 (%)
Held by Institutions	90.1 (%)
Shares Short	7,140 (K)
Shares Short P.Month	6,980 (K)

EPS	2.27
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	17.56
Profit Margin	23.2 %
Operating Margin	27.3 %
Return on Assets (ttm)	7.7 %
Return on Equity (ttm)	13.4 %
Qtrly Rev. Growth	14.6 %
Gross Profit (p.s.)	7.92
Sales Per Share	10.13
EBITDA (p.s.)	3.08
Qtrly Earnings Growth	-90.4 %
Operating Cash Flow	1,020 (M)
Levered Free Cash Flow	525 (M)

PE Ratio	35.85
PEG Ratio	0
Price to Book value	4.65
Price to Sales	8.06
Price to Cash Flow	46.5

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.